PIAA

CAS No. 851814-28-3

PIAA( —— )

Catalog No. M16191 CAS No. 851814-28-3

PIAA is a TBK1/IKKε inhibitor with IC50 of 0.40/1.07 uM, selectively accelerates proliferation of β-cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PIAA
  • Note
    Research use only, not for human use.
  • Brief Description
    PIAA is a TBK1/IKKε inhibitor with IC50 of 0.40/1.07 uM, selectively accelerates proliferation of β-cells.
  • Description
    PIAA is a TBK1/IKKε inhibitor with IC50 of 0.40/1.07 uM, selectively accelerates proliferation of β-cells; downregulates polyinosine:polycytidylic acid (poly I:C)-stimulated phosphorylation of interferon responsive factor-3 (IRF3), a substrate of TBK1/IKKε; augments β-cell-specific proliferation by increasing cAMP levels and mTOR activity via PDE3, improves glucose control and β-cell mass in the STZ-induced diabetic mouse model.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    IκB kinase (IKK)
  • Recptor
    IκB kinase (IKK)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    851814-28-3
  • Formula Weight
    265.268
  • Molecular Formula
    C16H11NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC=C(C=C1)C2=C3C=C(C=CC3=NO2)C=CC(=O)O
  • Chemical Name
    (E)-3-(3-phenylbenzo[c]isoxazol-5-yl)acrylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xu J, et al. Sci Rep. 2018 Oct 22;8(1):15587.
molnova catalog
related products
  • IKK2-IN-9

    IKK2-IN-9 is a potent, selective and orally active IKK2 inhibitor with IC50 of 19 nM.

  • GSK8612

    GSK8612 is a highly selective and potent Tank-binding Kinase-1 (TBK1 pIC50: 6.8).

  • INH14

    INH14 is a novel inhibitor of the IKKα/β-dependent TLR inflammatory response (IC50s: 8.97/3.59 μM for IKKα/IKKβ).